Novartis AG Common Stock (NVS)
SG&A Expenses
$3.24B
Quarterly · Period ending: · USD
NVS SG&A Expenses
Latest reported$3.24Bperiod ending
Latest reported$3.24Bperiod ending
NVS Quarterly SG&A Expenses ($0.00 → $3.24B)
Quarterly SG&A Expenses
High-resolution chart · PNG
NVS sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 1,720,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,647,000,000 | |
| 0 |